Xconomy

SEPTEMBER 10, 2019

Fall is finally arriving, as indicated by the recent shortened work week, and few may object given the unseasonably hot, muggy weather San Diego has been experiencing recently. Track down somewhere with AC, then catch up on recent developments in the local life sciences scene.

San Diego 46

San Diego Capital Develop Development 46

Xconomy

OCTOBER 25, 2018

The winner of the largest-ever startup pitch contest in San Diego is aiming to solve a problem that is weighing heavily on the national consciousness. The same day President Trump signed a bipartisan package of measures to address the opioid epidemic, San Diego startup NeuraLace Medical won $50,000 on Wednesday at the annual John G.

San Diego 107

San Diego Develop Development Startup 107

Xconomy

JUNE 10, 2016

Startup Week San Diego, like a lot of other places that host similar events, has been billed as a weeklong celebration of entrepreneurship. But while Startup Week San Diego has always collaborated with UP Global, San Diego entrepreneur and Startup Week organizer Austin Neudecker said, “We’ve always been an independent entity.”.

San Diego 74

San Diego Guide Tech Coast Angels Startup 74

Both Sides of the Table

OCTOBER 19, 2009

On December 2nd, 2006 I wrote the blog post published later in this post when I was CEO of startup Koral about my experiences in pitching VCs. After my company was acquired by Salesforce.com I was asked to stop blogging and they took over my blog as an asset in the sale of the company. My blog was wiped out.

Venture Capital 274

Venture Capital Blogging Startup Slides 274

Xconomy

OCTOBER 10, 2017

The San Diego artificial intelligence company Brain Corp. topped the chart for raising the most venture capital in San Diego during the third quarter that ended September 30, according to Venture Monitor data released Tuesday. As Xconomy reported in July, Brain Corp. As Xconomy reported in July, Brain Corp.

San Diego 48

San Diego Venture Capital Artificial Inteligence Funding 48

Xconomy

DECEMBER 12, 2016

Molecular Assemblies , a San Diego startup developing a new enzymatic method for synthesizing DNA, said today it has raised $2.3 The funding will be used to hire more scientists and to advance the company’s development of enzymatic DNA synthesis technology, CEO Michael Kamdar said in an interview Friday.

San Diego 40

San Diego Startup Invest Capital 40

Xconomy

SEPTEMBER 27, 2017

In San Diego, this higher order of social networking becomes apparent. Nowadays, Facebook is the most popular social networking site in the world , with more than 2 billion monthly active users. Yet somehow, the connections are richer and more meaningful when people come together offline and in-person.

San Diego 55

San Diego Social Media Social Network Yahoo 55

Xconomy

JULY 17, 2016

After the national MoneyTree Report was released last week, PricewaterhouseCoopers partner Ryan Spencer said he spent time on a call with Thomson Reuters, which provides the raw data, trying to figure out a change in the numbers for venture capital activity in San Diego. But the San Diego data was off. So the $350.5

San Diego 40

San Diego Venture Capital Funding Report 40

Xconomy

SEPTEMBER 19, 2016

Not long after ViaSat (NASDAQ: VSAT ) acquired San Diego-based LonoCloud in 2013 , former LonoCloud executives Tom Caldwell and Hossein Eslambolchi met for coffee at the Specialty’s Café and Bakery in University City. Webroot also plans to expand in San Diego, and Caldwell said he plans to stay on.

San Diego 40

San Diego Artificial Inteligence Universal City Chief Technology Officer 40

Xconomy

JULY 8, 2020

Dave Johnson has known UC San Diego physician and cancer reseacher Thomas Kipps for nearly 20 years. Read more » Reprints | Share: UNDERWRITERS AND PARTNERS.

San Diego 121

San Diego Develop Development UCSD 121

Xconomy

DECEMBER 20, 2018

The San Diego, CA, company made its public debut this week after starting up quietly earlier this year. The company also plans to develop drugs to tackle serious inflammatory diseases, although it hasn’t identified which it is aiming to treat.

Develop 67

Develop Development San Diego Study 67

Xconomy

NOVEMBER 13, 2016

The idea was to feature early stage companies in the region that have not attracted much attention or raised a substantial amount of startup capital. I started with a list of companies already screened by the San Diego Venture Group’s annual venture summit, and consulted with investors and startup mentors to refine the list. .

San Diego 40

San Diego Technical Review Artificial Inteligence Startup 40

Xconomy

SEPTEMBER 15, 2016

The Connect Innovation Report found that 405 software, technology, and life sciences startups were created last year in San Diego County. Software startups made up nearly 63 percent (255 companies created) of all new high-tech ventures created in 2015, a trend fueled chiefly by software app development, according to the report.

San Diego 40

San Diego Report High Tech Study 40

Xconomy

APRIL 17, 2018

The company developed automated kiosks that would scan a device and use analytic software to calculate what it was worth and how much of a rebate to offer for it. Founded by several veterans of the wireless semiconductor industry , EcoATM created a business where there wasn’t one for recycling smartphones and other electronic devices.

San Diego 79

San Diego Startup Sales Software 79

Xconomy

DECEMBER 19, 2018

Louis, MO-based venture capital firm with additional offices in San Diego, CA, and Cleveland, OH, has raised $184.4 Since its launch, RiverVest has invested in 47 companies working to develop new drugs and medical devices. RiverVest Venture Partners, a St.

San Diego 107

San Diego Funding Venture Capital Invest 107

Xconomy

APRIL 3, 2019

A 25-person startup developing advanced computing tools to speed up pathology work has raised its first institutional financing from a group of investors led by Intel Capital, the corporate investment arm of the chipmaker.

Artificial Inteligence 101

Artificial Inteligence San Diego Tool Invest 101

Xconomy

JUNE 23, 2020

Headed by president and CEO Niall O’Donnell (pictured), the San Diego-based company launched last year with $50 million and an investigational small molecule drug it licensed from High Point, NC-based vTv Therapeutics (NASDAQ: VTVT ). The molecule, REN001, is being developed for patients with primary mitochondrial myopathies (PMM).

San Diego 127

San Diego Study Design Develop 127

Xconomy

JUNE 17, 2020

Lassen Therapeutics, a biotech that is developing antibodies as potential treatments for fibrosis, rare diseases, and cancer, debuted Wednesday with $31 million in Series A financing. Lassen was started last year within Frazier Healthcare Partners; Mark Barrett, an entrepreneur in residence at the venture capital firm since 2017, is its CEO.

San Diego 71

San Diego Venture Capital Capital Entrepreneur 71

Xconomy

FEBRUARY 13, 2019

TuSimple has pulled in $95 million more in venture funding to advance its development of a commercial autonomous fleet of trucks. TuSimple, founded in 2015 in San Diego and Beijing, raised its Series C round of $55 million in late 2017. Composite Capital , a Hong Kong-based investment fund started in 2016, led that round.

San Diego 74

San Diego Company Companies Funding 74

Xconomy

JUNE 19, 2019

Now a former director from the company is leading a startup that has raised $15 million to develop new genome sequencing tools. San Diego’s Element Biosciences said Tuesday that it had secured a Series A round led by Foresite Capital, a healthcare and life sciences venture capital firm based in San Francisco, and Silicon Valley’s Venrock.

Tool 67

Tool Develop Development Venture Capital 67

Xconomy

MARCH 28, 2019

Founders Jared Tagney and Joshua Windmiller, who met while in grad school at UC San Diego, started the company in 2012 as Electrozyme. The company began focusing on the technology it is currently developing in 2015, Tagney said. The San Diego startup.

San Diego 103

San Diego Study Research Design 103

Xconomy

JUNE 26, 2020

Biotech veterans Tom Farrell and Peter Flynn have teamed up to start a new San Diego company that aims to develop allogeneic, or off-the-shelf, cell-based immunotherapies using natural killer (NK) cells that can be manufactured at scale and delivered to cancer patients outside of the hospital.

San Diego 107

San Diego Startup Services Develop 107

Xconomy

NOVEMBER 3, 2017

Klotho Therapeutics , a virtual biotech developing a kidney disease treatment based on its proprietary engineered version of the human klotho enzyme, said Thursday it has raised $10 million in Series A financing from San Diego’s Thynk Capital.

San Diego 85

San Diego Study Capital Technology 85

Xconomy

JUNE 18, 2020

Typically a new biotech assembles a group of investors that collectively puts in the money a fledgling company requires to develop or acquire potential therapies.

Develop 77

Develop Development Funding San Diego 77

Xconomy

APRIL 27, 2020

Serial biotech entrepreneur Jonathan Lim has raised a whopping $200 million to advance multiple candidates at his latest cancer drug development venture, Erasca, into human testing. The San Diego-based biotech, which started operations about 18 months ago, made its public debut in December 2018 with $42 million.

San Diego 76

San Diego Entrepreneur Develop Development 76

Xconomy

JANUARY 6, 2020

In the past seven years BioIntervene has been working to develop “ultra-selective” compounds to target an adenosine receptor associated with pain relief. Now the San Diego-based biotech has $30 million and a chief scientific officer, Charles Cohen, to guide its lead compound, BIO-205, into human testing for neuropathic pain.

San Diego 97

San Diego Guide Activity Develop 97

Xconomy

MARCH 22, 2019

Turning Point Therapeutics, which is developing targeted cancer drugs for patients whose tumors resist other precision therapies, has outlined plans for an IPO. The company, which started operations in 2014, has raised nearly $148 million since inception. Drugs already exist for some cancers associated with those.

San Diego 88

San Diego Develop Development Company 88

Xconomy

MAY 15, 2018

With the Bio-IT World Conference opening today in Boston, San Diego-based Illumina (NASDAQ: [[ticker:ILMN) said it has acquired Edico Genome, a five-year-old startup with technology to accelerate the readout of next-generation sequencing data. Illumina withheld terms of the deal in a statement released this morning.

San Diego 75

San Diego Conference Software Capital 75

Xconomy

NOVEMBER 8, 2018

San Diego is one of the top U.S. Researchers and entrepreneurs here are leaders in developing the next generation of medicines and medical devices. Hundreds of companies. Dozens of research institutes. Billions of dollars in economic impact. cities for innovation in life sciences and healthtech.

San Diego 82

San Diego Research Tool Entrepreneur 82

Xconomy

SEPTEMBER 19, 2019

The San Diego-based biotech came out of stealth mode Thursday with an announcement that it had raised a $46.4 million Series A financing round to fund the development of cancer drugs targeting tumors that have what’s known as extrachromosomal DNA. Zach Hornby, former chief.

San Diego 102

San Diego Funding Develop Development 102

Xconomy

SEPTEMBER 11, 2019

GlaxoSmithKline is acquiring a startup it helped launch in 2013 as part of an alliance with life sciences venture capital firm Avalon Ventures. Avalon said Tuesday that GSK (NYSE: GSK ) has agreed to buy the company, Sitari Pharmaceuticals, which has been developing a treatment for celiac disease.

Avalon 56

Avalon Invest Southern California Develop 56

Xconomy

MARCH 26, 2020

Forge Therapeutics has set an agreement with Roche that gives the Swiss pharma giant the option to license a new antibiotic Forge is developing to treat serious drug-resistant bacterial lung infections.

San Diego 82

San Diego Develop Development Venture Capital 82

Xconomy

NOVEMBER 7, 2017

Progenity, a San Diego molecular diagnostics company focused on women’s health, reproductive medicine, and oncology, has raised $125 million in a Series B financing led by New York’s Athyrium Capital Management, an earlier investor. Read more » Reprints | Share: UNDERWRITERS AND PARTNERS.

San Diego 52

San Diego Equity Capital Develop 52

Xconomy

OCTOBER 19, 2018

The San Diego-based biotech, which is developing targeted cancer drugs for people whose tumors resist other precision therapies, announced the changes Friday. Five-year-old biotech TP Therapeutics has raised an $80 million mezzanine financing round and promoted its chief medical officer, Athena Countouriotis, to CEO.

San Diego 97

San Diego Develop Development Venture Capital 97

Xconomy

OCTOBER 24, 2016

Intel Capital has invested $38 million in 12 technology startups since July, highlighting its venture investment focus on innovations in self-driving cars and machine vision, the Internet of Things, sports and health, drones, and virtual reality. We need to be on a path-finding mission to find tangential investments,” he told reporters.

Capital 40

Capital San Diego Invest USC 40

Xconomy

APRIL 22, 2019

Swiss pharma giant Novartis has invested $75 million in a $142 million Series C round for San Diego-based Poseida, which is one of several companies developing what is meant to be a one-time, long-lasting treatment for multiple myeloma.

San Diego 83

San Diego Study Funding Invest 83

Xconomy

OCTOBER 2, 2019

Organovo, a company developing technology to 3D print human tissue, announced two months ago that its dwindling cash is leading it to explore options that include merging with another firm. The San Diego biotech now has an offer from a familiar face close to home.

San Diego 61

San Diego Startup Technology Develop 61